What We're Reading: Page 169
Industry reads hand-picked by our editors
Nov 19, 2020
Nov 18, 2020
Nov 17, 2020
-
NPR
China Is Vaccinating Thousands Against COVID-19 With Unapproved Vaccines
-
CNBC
Amazon jumps into the pharmacy business with online prescription fulfillment, free delivery for Prime members
-
The Hill
Trump officials preparing to move forward with major step to lower Medicare drug prices
-
Reuters
U.S. hospitals to restrict Lilly COVID-19 antibody treatment due to limited supply
Nov 16, 2020
-
FiercePharma
2020's Fiercest Women in Life Sciences
-
Pittsburgh Business Times
After nearly 60 years, Mylan makes way for Viatris
-
Endpoints News
Sanofi grapples with rejection of potential first-in-class orphan drug, faults third-party manufacturing
-
TCT MD
Fish Oil Tanks in STRENGTH, Making Waves For REDUCE-IT
Nov 13, 2020
-
The Wall Street Journal
How a Coronavirus Vaccine Maker’s Stock Went From Dud to Star
-
Bloomberg
J&J Taps UnitedHealth to Accelerate Vaccine Trial
-
STAT
An FDA adviser on why his panel didn't endorse Biogen's Alzheimer's drug
-
Endpoints News
Doubling down on Sanofi's French roots, Paul Hudson infuses €50M into Jeito Capital to boost homegrown biotechs
Nov 12, 2020
-
Wired
More Safety Data Would Be Nice, But We Need a Vaccine Now
-
The Wall Street Journal
Kodak Says Ex-Executives Sold Stock Options They Didn’t Own
-
Science
Russia's claim of a successful COVID-19 vaccine doesn’t pass the 'smell test,' critics say
-
NPR
Novavax Releases Federal Contract To Develop COVID-19 Vaccine
Previous
